Bassil I Dahiyat Xencor Inc (XNCR) insider trading activity

Bassil I Dahiyat is PRESIDENT & CEO of Xencor Inc. Currently has a direct ownership of 366,163 shares of XNCR, which is worth approximately $8.89 Million. The most recent transaction as insider was on Nov 22, 2024, when has been sold 13,548 shares (Common Stock) at a price of $15.69 per share, resulting in proceeds of $212,568. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 366K

4.05% 3M change

25.31% 12M change

Total Value Held $8.89 Million

Bassil I Dahiyat Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 22 2024	BUY Exercise of conversion of derivative security	$212,568 $15.69 p/Share	13,548 Added 3.57%	366,163 Common Stock
Nov 21 2024	SELL Open market or private sale	$1,186,121 $24.07 p/Share	49,278 Reduced 12.26%	352,615 Common Stock
Nov 21 2024	BUY Exercise of conversion of derivative security	$773,171 $15.69 p/Share	49,278 Added 10.92%	401,893 Common Stock
Nov 13 2024	SELL Open market or private sale	$80,851 $24.02 p/Share	3,366 Reduced 0.95%	352,615 Common Stock
Nov 13 2024	BUY Exercise of conversion of derivative security	$52,812 $15.69 p/Share	3,366 Added 0.94%	355,981 Common Stock
Mar 11 2024	SELL Open market or private sale	$64,413 $23.5 p/Share	2,741 Reduced 0.77%	351,894 Common Stock
Mar 05 2024	SELL Open market or private sale	$293,531 $23.43 p/Share	12,528 Reduced 4.01%	300,097 Common Stock
Mar 05 2024	BUY Grant, award, or other acquisition	-	54,538 Added 13.33%	354,635 Common Stock
Dec 29 2023	SELL Open market or private sale	$941,850 $20.93 p/Share	45,000 Reduced 12.57%	312,929 Common Stock
Dec 29 2023	BUY Exercise of conversion of derivative security	$718,261 $11.05 p/Share	65,001 Added 15.37%	357,929 Common Stock
Jun 21 2023	SELL Open market or private sale	$877,286 $26.19 p/Share	33,497 Reduced 10.28%	292,216 Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	$323,051 $4.25 p/Share	76,012 Added 18.92%	325,713 Common Stock
Mar 09 2023	SELL Open market or private sale	$77,747 $29.88 p/Share	2,602 Reduced 1.03%	249,701 Common Stock
Mar 06 2023	SELL Open market or private sale	$183,210 $31.42 p/Share	5,831 Reduced 2.26%	252,303 Common Stock
Mar 03 2023	SELL Open market or private sale	$89,920 $31.54 p/Share	2,851 Reduced 1.09%	258,134 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	52,521 Added 16.75%	260,985 Common Stock
Mar 09 2022	SELL Open market or private sale	$72,326 $29.0 p/Share	2,494 Reduced 1.19%	207,815 Common Stock
Mar 03 2022	SELL Open market or private sale	$87,577 $29.9 p/Share	2,929 Reduced 1.79%	160,548 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	49,761 Added 19.13%	210,309 Common Stock
Mar 08 2021	BUY Grant, award, or other acquisition	-	21,999 Added 11.89%	163,063 Common Stock
Mar 03 2021	SELL Open market or private sale	$127,908 $44.88 p/Share	2,850 Reduced 1.98%	141,064 Common Stock

Also insider at

KOD

Kodiak Sciences Inc. Healthcare

BID

Bassil I Dahiyat

PRESIDENT & CEO

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XNCR shares.

Notify only if

Value

Insider Trading

Get notified when an Xencor Inc insider buys or sells XNCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Xencor Inc

Track Activities on XNCR

Account